Literature DB >> 7274873

Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asian vs Western populations.

T Okuma.   

Abstract

The effects and side-effects of psychotropic drugs are determined by many variables, and the host factor is one of the most important. A lower sensitivity of schizophrenics than normals to the sedative effect of chlorpromazine and a manic depressives to imipramine were demonstrated quantitatively by a higher percent time of waking EEG following medication. The mean therapeutic dose of chlorpromazine for the manic state was found to be much lower in Japanese than in Western populations in a controlled study comparing the antimanic efficacy of carbamazepine and chlorpromazine. A lower therapeutic dose in Asian populations has been reported also on other antipsychotic drugs, lithium, and tricyclic antidepressants. The lower therapeutic dose level was discussed from the standpoint of transcultural psychopharmacology.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7274873     DOI: 10.1111/j.1440-1819.1981.tb00203.x

Source DB:  PubMed          Journal:  Folia Psychiatr Neurol Jpn        ISSN: 0015-5721


  6 in total

Review 1.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

2.  Ethnicity and psychopharmacology.

Authors:  K M Lin; R E Poland; I M Lesser
Journal:  Cult Med Psychiatry       Date:  1986-06

3.  Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type.

Authors:  Mohammad Hossain; Stanford S Jhee; Thomas Shiovitz; Craig McDonald; Greg Sedek; Francoise Pommier; Neal R Cutler
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam.

Authors:  T Okuma; H Matsuoka; Y Matsue; K Toyomura
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 5.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events.

Authors:  Paul Goldsmith; John Affinito; Maggie McCue; Max Tsai; Stefan Roepcke; Jinhui Xie; Lev Gertsik; Thomas A Macek
Journal:  Drugs R D       Date:  2017-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.